Free shipping on all orders over $ 500

Dioscin

Cat. No. M3921

All AbMole products are for research use only, cannot be used for human consumption.

Dioscin Structure
Synonym:

CCRIS 4123, Collettiside III

Size Price Availability Quantity
5mg USD 30  USD30 In stock
10mg USD 40  USD40 In stock
25mg USD 60  USD60 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

Dioscin suppressed HL-60 cell growth in a dose-dependent manner. Dioscin induces apoptosis by activation of p38 MAPK and JNK through the caspase-dependent mitochondrial death pathway. Dioscin may be used as a compound lead for the treatment of myeloblast leukemia. Dioscin may be a potential anticancer drug, which efficiently inhibits angiogenesis induced by VEGFR2 signaling pathway as well as AKT/MAPK pathways. Dioscin alleviated body weight and liver lipid accumulation symptoms, increased oxygen consumption and energy expenditure, and improved the levels of serum and hepatic biochemical parameters. Dioscin significantly attenuated oxidative damage, suppressed inflammation, inhibited triglyceride and cholesterol synthesis, promoted fatty acid β-oxidation, down-regulated MAPK phosphorylation levels, and induced autophagy to alleviate fatty liver conditions. Dioscin prevents diet induced obesity and NAFLD by increasing energy expenditure.

Chemical Information
Molecular Weight 869.04
Formula C45H72O16
CAS Number 19057-60-4
Solubility (25°C) DMSO 90 mg/mL
Storage Powder          -20°C   3 years ;  4°C   2 years
In solvent       -80°C   6 months ;  -20°C   1 month
References

[1] Liu M, et al. Sci Rep. Potent effects of dioscin against obesity in mice.

[2] Poudel B, et al. Int J Mol Med. Dioscin inhibits adipogenesis through the AMPK/MAPK pathway in 3T3-L1 cells and modulates fat accumulation in obese mice.

[3] Tong Q, et al. Toxicol Appl Pharmacol. Dioscin inhibits colon tumor growth and tumor angiogenesis through regulating VEGFR2 and AKT/MAPK signaling pathways.

[4] Tao X, et al. Transplantation. Dioscin attenuates hepatic ischemia-reperfusion injury in rats through inhibition of oxidative-nitrative stress, inflammation and apoptosis.

[5] Kim EA, et al. Apoptosis. Dioscin induces caspase-independent apoptosis through activation of apoptosis-inducing factor in breast cancer cells.

[6] Wang Y, et al. Eur J Pharmacol. Dioscin induced activation of p38 MAPK and JNK via mitochondrial pathway in HL-60 cell line.

Related Autophagy Products
Vacuolin-1

Vacuolin-1 is a cell-permeable inhibitor of Ca2+ dependent fusion of lysosomes to the cell membrane. Vacuolin-1 blocks the Ca2+-dependent exocytosis of lysosomes and prevents the release of lysosomal content without affecting the process of resealing. vacuolin‐1 is a potent and selective PIKfyve inhibitor and inhibits late‐stage autophagy by impairing lysosomal maturation.

CA77.1 

CA77.1 is a potent, brain-penetrant and orally active chaperone-mediated autophagy (CMA) activator with favorable pharmacokinetics.

KAN0438757 

KAN0438757 is a potent and selective inhibitor of the metabolic kinase PFKFB3 with an IC50 of 0.19 μM.

Metofenazate

Metofenazate is a selective calmodulin inhibitor.

Patulin

Patulin (Terinin) is a mycotoxin produced by a variety of fungi, causes chromosome breakage, mutation, teratogenic and cytotoxic. Patulin induces autophagy-dependent apoptosis through lysosomal-mitochondrial axis, and causes DNA damage.

  Catalog
Abmole Inhibitor Catalog




Keywords: Dioscin, CCRIS 4123, Collettiside III supplier, Autophagy, inhibitors, activators

All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.